- Home
- MMU vs TLRY Comparison
MMU vs TLRY Comparison
Compare MMU & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMU | TLRY |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.5M | 570.4M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MMU | TLRY |
|---|---|---|
| Price | $10.09 | $4.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 128.8K | ★ 3.7M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.79 | $0.55 |
| 52 Week High | $10.71 | $15.70 |
Technical Indicators
Market Signals| Indicator | MMU | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 30.98 |
| Support Level | $9.91 | $0.77 |
| Resistance Level | $10.47 | $4.85 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 9.41 | 25.48 |
Price Performance
Historical ComparisonAbout MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.